Trending
November 4, 2024 Alexandria Venture Investments Join $10M Seed Financing For CrossBridge BioNovember 4, 2024 Cornucopian Capital Joins $20M Round for Archon BiosciencesOctober 30, 2024 Alexandria Venture Investments Join $115 Million Series A For Axonis TherapeuticsOctober 30, 2024 Alexandria Venture Investments Joins $45M Financing For Leal TherapeuticsOctober 16, 2024 Amazon Leads $500 Million Series C-1 Financing of X-energy
Featured
November 4, 2024
Alexandria Venture Investments Join $10M Seed Financing For CrossBridge Bio
HOUSTON--(BUSINESS WIRE)--CrossBridge Bio, a biotechnology company pioneering dual-payload antibody-drug conjugates... Read more »
November 4, 2024
Cornucopian Capital Joins $20M Round for Archon Biosciences
Pasadena, Calif.-based Alexandria Venture Investments, a subsidiary of Alexandria Real Estate Equities (NYSE: ARE), has... Read more »
October 30, 2024
Alexandria Venture Investments Join $115 Million Series A For Axonis Therapeutics
Axonis Therapeutics, a biotechnology company focused on the development of novel neuromedicines, announced today the... Read more »
